ATR-1072

N/A

Report date: 2026/05/12 15:11:27

Base Information

Drug NameATR-1072
Drug Alias NameAOC 1072AOC-1072ATR-1072ATR1072
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNABiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate > Antibody-Oligonucleotide conjugate
Mechanisms of Action5'-AMP-activated protein kinase subunit gamma-2 modulators
Targets5'-AMP-activated protein kinase subunit gamma-2
Therapy Area/IndicationsPRKAG2 Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvidity Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAtrium Therapeutics IncAvidity Biosciences Inc
Inactive CompaniesN/A
Active IndicationsPRKAG2 Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A